Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis Patients, Single-Center, Prospective, Open-Label, Single-Arm Clinical Trial, Long-Term Follow-up

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder with very limited treatment options. Stem cells have been raised as a new treatment modality for these patients. We have designed a single-center, prospective, open-label, and single arm clinical trial to assess the safety, fe...

Descripción completa

Detalles Bibliográficos
Autores principales: Nabavi, Seyed Massood, Karimi, Shahedeh Karimi, Arab, Leila, Sanjari, Leila, Mardpour, Soura, Azimian, Vajiheh, Jarughi, Neda, Ghaheri, Azadeh, Hosseini, Seyedeh-Esmat, Aghdami, Nasser, Vosough, Massoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royan Institute 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753106/
https://www.ncbi.nlm.nih.gov/pubmed/34979067
http://dx.doi.org/10.22074/cellj.2021.7984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753106/
https://www.ncbi.nlm.nih.gov/pubmed/34979067
http://dx.doi.org/10.22074/cellj.2021.7984

Ejemplares similares